Patents by Inventor Kangwen Lin

Kangwen Lin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Formulations for benzimidazolyl pyridyl ethers
    Patent number: 8455662
    Abstract: Formulations are provided, comprising: a compound of Formula I, a pharmaceutically acceptable salt thereof, or a mixture of any two or more thereof; and an ingredient selected from a hydrophilic solvent, a lipophilic solvent, an emulsifier, or a mixture of any two or more thereof; wherein the compound of Formula I is: In some embodiments, the formulations are liquids. In other embodiments, the formulations are solids. Also provided are methods of preparing such formulations.
    Type: Grant
    Filed: July 20, 2007
    Date of Patent: June 4, 2013
    Assignee: Novartis AG
    Inventors: Ahmad Hashash, Sean Ritchie, Kangwen Lin, Peng Shen, Augustus Okhamafe, Rampurna Gullapalli
  • FORMULATIONS FOR BENZIMIDAZOLYL PYRIDYL ETHERS
    Publication number: 20100040677
    Abstract: Formulations are provided, comprising: a compound of Formula I, a pharmaceutically acceptable salt thereof, or a mixture of any two or more thereof; and an ingredient selected from a hydrophilic solvent, a lipophilic solvent, an emulsifier, or a mixture of any two or more thereof; wherein the compound of Formula I is: In some embodiments, the formulations are liquids. In other embodiments, the formulations are solids. Also provided are methods of preparing such formulations.
    Type: Application
    Filed: July 20, 2007
    Publication date: February 18, 2010
    Inventors: Ahmad Hashash, Sean Ritchie, Kangwen Lin, Peng Shen, Augustus Okhamafe, Rampurna Gullapalli
  • Crystalline forms of 9-(S)-erythromycylamine
    Publication number: 20050250714
    Abstract: The present invention provides novel crystalline forms of the macrolide antibiotic 9-(S)-erythromycylamine, and methods of preparing and using the same.
    Type: Application
    Filed: May 5, 2005
    Publication date: November 10, 2005
    Inventors: Kangwen Lin, Augustus Okhamafe, Patricia Frech
  • Stabilized, acid-free formulation for sustained release of bupropion hydrochloride
    Patent number: 6306436
    Abstract: Stabilized bupropion hydrochloride pharmaceutical compositions are disclosed that are free of acid additives and provide for a sustained release of the bupropion hydrochloride. The particulate bupropion hydrochloride may be coated with a membrane coating and large-size particles may also be used. Methods for treating individuals using the stabilized bupropion hydrochloride pharmaceutical compositions are also provided.
    Type: Grant
    Filed: April 28, 2000
    Date of Patent: October 23, 2001
    Assignee: Teva Pharmaceuticals USA, Inc.
    Inventors: Shubha Chungi, Kangwen Lin